After moving to the UK from Kingston, Jamaica, Andrew completed his studies at St Andrews University (BSc Hons Plant Biology) and Aberdeen University/The Rowett Institute (PhD, Molecular Microbiology).
He has worked in the Medical Research field in infectious diseases (UK), hormone dependent cancers (Australia) and pluripotent stem cell applications (Singapore), with an interest in RNA regulatory mechanisms (including microRNAs) where he has published in journals such as Nature, Cell, Nucleic Acids Research. He has also worked in the assay development field of new and emerging diseases and biothreats with the UK government and held senior positions in industry in vaccine development. He has also held senior positions in Process Development and Manufacturing in gene and stem cell-based therapeutics. Throughout, he has employed a Quality by Design approach for assays, process development and manufacturing processes from early to commercial phases. He brings experience and a wealth of knowledge in microbiology, molecular and cellular biology, assay development, process development and manufacturing across a broad spectrum, including CDMO management.
Andrew is a co-founder, Managing Partner and Director of GreyRigge Associates 合同会社 (GK) in Kobe, Japan, developing a professional network across the Asia/Australia region.
